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8S Abstracts May Supplement 2013median baseline hsCRP was 6.2 mg/L (IQR, 2.4-10). Most
vein grafts (68%) were single-segment great saphenous vein
and 63% were femoral-popliteal bypasses. Mean baseline
brachial artery FMD was 7.6 6 4.5%. Mean graft lumen
diameter increased from 4.3 6 0.8 mm at surgery to 4.7 6
0.8 mm at 3 months. There was a signiﬁcant correlation
between initial lumen diameter and 0-3 months remodeling
(r¼.48;P¼ .02).No correlationwas seenbetween brachial
FMD and vein graft FMD. Mature ($12 months) grafts had
signiﬁcantly higher FMD than early (3 months) grafts (4.56
2.7% vs 0.6 6 1.9%; P < .0005) and there was a signiﬁcant
positive correlation between early and late graft FMD (r ¼
.64; P ¼ .01). We did not observe a signiﬁcant correlation
between early graft remodeling and either brachial or vein
graft FMD.
Conclusions: LEVBG patients have endothelial
dysfunction demonstrated by impaired brachial artery
FMD. Veins grafts exhibit recovery of endothelial function
over the ﬁrst year of implantation. However, early
geometric remodeling appears asynchronous from physio-
logic endothelial recovery in the aterialized vein.
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The Society for Vascular Surgery’s Objective
Performance Goals for Critical Limb Ischemia Are
Attainable With Contemporary Endovascular Therapy
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Douglas W. Jones, John K. Karwowski, Harry L. Bush,
Darren B. Schneider. Vascular Surgery, Weill Cornell
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Objectives: The Society for Vascular Surgery’s Objec-
tive Performance Goals (SVS OPGs) for critical limb
ischemia (CLI) are derived from bypass surgery outcomes
in a pooled cohort from 3 randomized trials. We examine
the effectiveness of endovascular therapy (ET) for CLI in
using OPG efﬁcacy benchmarks.
Methods: CLI patients undergoing ET (2006-2012),
were identiﬁed in a prospectively maintained database.
Unadjusted outcomes were used for comparisons to theTable. One year results with endovascular therapy compared
Outcome metric
Overall
OPG (n ¼ 838) Endo (n ¼
Major adverse limb event or post-op death (MALE +
POD)
71% 73 6 3%
Amputation-free survival (AFS) 71% 66 6 3%
Reintervention, amputation, or stenosis (RAS) 39% 43 6 4%
Reintervention or amputation (RAO) 55% 60 6 4%
Limb salvage 84% 85 6 3%
Survival 80% 74 6 3%
Rates reported as freedom from adverse events.overall OPG cohort, as well as between anatomic and clin-
ical high-risk subgroups. ET-speciﬁc regression models for
each OPG end point identiﬁed risk factors for poor
outcome.
Results: 283 CLI patients underwent ET for tissue
loss (77%) or rest pain. Compared to the OPG cohort
(n ¼ 838), patients undergoing ET were more likely to
be >80 years old (32% vs 19%; P < .0001), female (51%
vs 34%; P < .0001), have end stage renal disease (ESRD)
(15% vs 0%; P < .0001), or anatomic high-risk features
(73% vs 60%; P ¼ .002). The mean reintervention rate after
ET was 0.67 per limb-year. The overall effectiveness of ET,
with subgroup analysis, is summarized in the Table.
Conclusions: Although survival-based benchmarks
may be difﬁcult to achieve in “real world” practice that
includes poor surgical candidates and those with ESRD,
most SVS OPGs are attainable with contemporary endo-
vascular therapy. These ﬁndings not only support the role
of ET in the management of CLI, but underscore the
utility of SVS OPGs for comparative effectiveness and
outcomes research.
Author Disclosures: H. L. Bush: Nothing to disclose; P.
H. Connolly: Nothing to disclose;H. L. Gill: Nothing to
disclose;D. W. Jones: Nothing to disclose; J. K. Karwow-
ski: Nothing to disclose; A. J. Meltzer: Nothing to
disclose; D. B. Schneider: Nothing to disclose.V2:PeripheralVascular Surgery SocietyPaper Session II
PVSS11.
Intervention, Failure Mechanism, Patency, Wound
Complications, and Limb Salvage in Open Versus
Endoscopic Greater Saphenous Vein Harvest for
Lower Extremity Revascularization
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Timothy K. Liem, Erica L. Mitchell, Amir F. Azarbal,
Gregory L. Moneta. General Surgery, Oregon Health &
Science University, Portland, Ore
Objectives: Determine intervention rates, failure
mechanisms, patency, wound complications and limb
salvage after lower extremity revascularization using open
(OVH) vs endoscopic vein harvest (EVH).
Methods: Single institution review of consecutive
patients between 2005 and 2012, who underwent infrain-
guinal bypass with reversed greater saphenous vein (GSV).to suggested OPGs
Clinical high risk Anatomic high risk
283) OPG (n ¼ 136) Endo (n ¼ 56) OPG (n ¼ 505) Endo (n ¼ 206)
61% 69 6 8% 67% 73 6 5%
53% 60 6 7% 68% 66 6 4%
29% 47 6 8% 36% 56 6 5%
54% 53 6 8% 51% 59 6 5%
80% 82 6 7% 81% 83 6 4%
63% 69 6 7% 80% 77 6 4%
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with open and 118 with endoscopic GSV harvest. There
were no differences between groups in age, medical co-
morbidities, smoking status, prior interventions, treatment
indication (CLI: 81% OVH, 83% EVH), or proximal/distal
anastomotic site. Mean operative times were 262 minutes
for OVH and 323 minutes for EVH (P < .001). Mean
follow-up was 556 days (OVH) and 595 days (EVH).
18% of OVH grafts and 28% of EVH grafts had an interven-
tion during follow-up (P ¼ .048). Median time to interven-
tion was 201 days (OVH) vs 126 days (EVH) (P ¼ .192).
Amongst interventions, there was no difference in the
number that were surgical: 51.4% (OVH) vs 63.6%
(EVH) (P ¼ .337). Mean number of stenoses treated per
intervention was 1.1 (OVH) vs 1.2 (EVH) (P ¼ .552).
Median stenosis length was 2.1 cm (OVH) vs 2.6 cm
(EVH) (P ¼ .724). Three-year primary patency was 51%
(OVH) vs 41% (EVH) (P ¼ .057). Secondary patency at
three years was 72% (OVH) vs 63% (EVH) (P ¼ .325).
Overall and harvest related wound complications were
44.8% and 28% (OVH) vs 33.9% and 10.8% (EVH) (P ¼
.059 and P < .001). Limb salvage for CLI was 88.9%
(OVH) and 91.2% (EVH) at 3 years (P ¼ .646).
Conclusions: OVH and EVH have similar long-term
patency, failure mechanisms and limb salvage. Harvest
related wound complications are less with EVH but overall
wound complications are similar and operative times are
longer for EVH and more interventions are required for
EVH to maintain patency. Open GSV harvest is preferred
to EVH for infrainguinal reconstructions in a predomi-
nantly CLI population.
Author Disclosures: A. F. Azarbal: Nothing to disclose;
P. Dargon: Nothing to disclose; G. J. Landry: Nothing
to disclose; T. K. Liem: Nothing to disclose; E. L. Mitch-
ell: Nothing to disclose; G. L. Moneta: Nothing to
disclose; V. J. Santo: Nothing to disclose.PVSS12.
Lower and Upper Extremity Arterial Bypasses in 38
Preadolescent Children
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Objectives: Arterial reconstructions requiring bypass
for extremity disease in pediatric patients are uncommon.
The intent of this study is to deﬁne differences between
upper and lower extremity reconstructions in regard to:
reasons for treatment and long-term outcomes.
Methods: Upper extremity bypasses were performed
in 10 children, 6 months to 12 years in age (mean 7.1
years), for: penetrating (2) and blunt (5) trauma, as well
as for asymptomatic aneurysms (3). Lower extremity
bypasses were performed in 28 children, 2 months to 10
years in age (mean 5.5 years), for: non-acute catheter-
related (23) or idiopathic (2) occlusions, non-iatrogenic
trauma (2), and aneurysm (1).
Results: All upper extremity bypasses were con-
structed with autogenous saphenous vein as interposition
brachial (8) or axillary (1) artery grafts, and an axillobra-
chial arterial graft (1). Upper extremity bypass follow-up
averaged 4.1 years with sustained patency and no evidenceof graft deterioration. All but one of the lower extremity
bypasses were constructed with autogenous vein; the single
exception utilized PTFE when no suitable vein existed.
Bypasses involved the iliofemoral (23) and femoropopliteal
(5) arteries. Grafts traversing the abdominal cavity were
preferentially covered with a Dacron mesh to limit later
aneurysmal changes. Follow-up of lower extremity recon-
structions averaged 10.3 years. Five major complications
occurred, including: late vein graft occlusions (4) and aneu-
rysmal vein graft deterioration (1). Symptomatic ischemia
in 14 patients resolved in all but one child, and preopera-
tive limb-length discrepancies in 17 children ceased to be
progressive. No major perioperative complications or oper-
ative mortality occurred in this experience.
Conclusions: Upper and lower extremity arterial
bypasses with autogenous saphenous vein may be per-
formed successfully in preadolescent children. Lower
extremity reconstructions warrant careful long-term
follow-up given the potential for late graft occlusion and
aneurysmal changes.
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Seen in patients With Marfan, Vascular Ehlers Danlos
and Loeys-Dietz Syndrome
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Objectives: Endovascular means to address arterial
problems in patients with Connective Tissue Disorders
(CTDs) has been viewed skeptically. We report the long
term outcomes of CTD patients treated for peripheral
vascular (PV) problems.
Methods: A retrospective review was conducted to
identify all patients with diagnosed CTDs (1975-2012).
Patients with genetic testing who met diagnostic criteria
guidelines for Marfan (MS), Vascular Ehlers Danlos
(EDS) and Loeys-Dietz Syndrome (LDS) were included.
Demographics, genetic data, treatment indication, and
outcomes were analyzed.
Results: A total of 480 patients were identiﬁed, with
63 patients (13%) fulﬁlling the inclusion criteria and pre-
senting with PV rather than cardiac issues. Over a mean
follow-up of 10.2 6 6.6 years, a total of 197 primary
[151 open surgical (OS); 46 endovascular procedures
(EP)] and 82 secondary procedures [64 OS; 18 EP] were
performed. Of the EP, 22 were hybrid (18 aortic and 4
cerebrovascular) with the rest being isolated EP. Seven
patients died as a result of vascular complications (5 OS,
2 EP; 4 during the perioperative period). There were 13
addtional deaths not related to vascular problems. EDS
patients had a higher incidence of infradiaphragmatic aor-
toiliac, while LDS patients had more supra-aortic trunk
aneurysms.
